Our Team

Ricky Myers

Chief Executive Officer

Ricky Myers serves as the CEO of RAM Pharmaceuticals, where he leads the company’s efforts in developing innovative treatments for painful oral lesions and spearheads the Cancer Comfort Care initiative. He oversees the strategic direction of RAM’s product portfolio, including the pursuit of FDA approvals for groundbreaking therapies targeting severe oral mucositis in cancer patients. Triamdocaine™ received FDA IND approval on November 11, 2023, and is currently in Phase 2 clinical trials. With over 30 years of experience in business management and entrepreneurship, he is committed to enhancing patient care and comfort through effective pharmaceutical solutions.

Aaron Deves

Aaron Deves

Strategic Advisor
Aaron is an enterprising executive leader with 28 years of experience in the life sciences industry. He has a diverse background in strategic planning, brand development, marketing, market access, operations, and sales management across various sectors, including biologics, vaccines, and small molecules, at various stages of the product life cycle. His expertise extends to global commercialization and the evaluation of asset opportunities, which have led to multiple business development deals and product agreements. Aaron has directly led or played a critical role in numerous successful brand launches. Throughout his career, he has demonstrated a remarkable ability to manage complex situations and teams, earning him a reputation for excellence in the field of life sciences. Aaron is currently the Founder and CEO of Ocean Ridge Strategy Group LLC, where he provides commercial and development advisory services to Life Sciences Companies. Before founding Ocean Ridge Strategy Group, he held significant positions at leading pharmaceutical companies, including Teva Pharmaceuticals, Otsuka Pharmaceuticals, Pfizer, and Wyeth.

Advisory Board Members

Cliff Osbon​

Cliff brings over 35 years’ experience in pharmacy and business development leadership. A licensed pharmacist since 1984, he served as President of Transcript Pharmacy, Inc., from 2002 to 2018. During this time, Cliff secured capital investments for initial funding and long-term financing, and crafted and managed marketing and sales plan for business growth to a high of $105M in annual sales. In January 2018, Transcript Pharmacy, Inc., merged with Nobile Health Services, Inc., and Cliff became Vice President, Business Development and Trade Relations. Currently the franchisee and co-owner of Southern Office Solutions, LLC, Cliff is also consultant and principal of Fort Miro Professional Services, LLC, where he provides management and business development consulting services to healthcare businesses and stakeholders.

Cliff was named Mississippi Business Journal’s Top Entrepreneur in 2020 and serves as Mississippi Pharmacists Association Committee Chair for the Government Affairs Committee and PAC Committee.

Scotte Hudsmith​

Scotte Hudsmith currently serves as Chairman and CEO of Specialized Dental Partners, a Dental Support Organization that supports 250-plus locations in 33 states and 400-plus dental specialists that focus on Endodontics, Oral Surgery and Periodontics. Prior to his current roles, Scotte was the Chairman & Chief Executive Officer of Smile Doctors, where he co-founded and guided the executive leadership team during the company’s expansion to become the world’s largest Orthodontic Support Organization. He continues to serve Smile Doctors as Chairman Emeritus.

Hudsmith has more than 30 years of corporate leadership experience, including executive roles in finance, operations, business development and sales and marketing. He specializes in developing and implementing growth strategies in healthcare companies that are private equity-backed and has extensive experience coordinating mergers and acquisitions. He also holds several board appointments for PE funds, private and nonprofit organizations.

Liza Cirlot Looser

Liza is the founder and CEO of The Cirlot Agency, a leading global brand strategy, integrated communications and business development firm. Over the past 40 years, the firm has grown to represent publicly traded companies and privately held corporations on a national and international basis. A graduate of Harvard Business School and Mississippi University for Women, Liza has expanded her studies to include several international business studies and special assignments. As a testament to her international business acumen, Liza’s experience includes representation of clients in China, Europe, Africa, South America and the Middle East. Liza has dedicated her career to domestic and international corporations in the healthcare, aerospace, defense, manufacturing, finance, technology, telecommunications and food products industries.

Most recently, Liza was appointed Chairman of the Board of the Center of Innovation and Entrepreneurship at the University of Mississippi. In 2016, Liza was named among Mississippi’s Top CEO’s and received the Silver Medal Award from the American Advertising Federation, which recognizes men and women who have made outstanding contributions to advertising. Among the Agency’s hundreds of awards and accolades is the Corporate World Class Supplier Award presented annually by Northrop Grumman Corporation. The Cirlot Agency was one of ten suppliers in the United States who consistently demonstrated outstanding achievements and support of Northrop Grumman programs.

Charlie Sundling​

Charlie provides nearly 30 years of leadership experience in technology design and development. A self-proclaimed “serial entrepreneur,” he has founded more than a dozen companies that have provided solutions to customers in 40+ countries. Charlie holds patents on advanced technology used by nuclear power and oil & gas industries, and is a regular speaker on integrated asset management and advanced workforce optimization. He is a published author on enterprise software technology, including the best-selling, “CRM at the Speed of Light” (McGraw Hill), for which he was a contributing author. Through his writings, he has also introduced advanced concepts, such as the use of artificial intelligence in mega project controls (London Expo, 2015). Charlie’s 20 years of CEO experience includes a comprehensive understanding of mergers, acquisitions, complex transactions, supply chains, and international operations.

In addition to his private sector work, Charlie has nearly a decade of public sector experience. He served five years on the board of Washington, DC-based TechAmerica, the largest technology and defense industry group in the U.S., including serving on the executive board and chairing such committees as the International Policy & Trade Committee. He also served on advisory committees to the Securities Exchange Commission, and participated in special US envoys to the European Commission.

Dale Hubbard​

With nearly 50 years’ leadership experience, Dale brings expertise in sales, acquisitions, and consulting. Following nearly a decade as president of Hubbard-Lawson Building Specialties, he was managing partner of a private law firm for 16 years. In 1998, Dale entered the telecommunications market as a principal in CommuniSite Cellular Towers, LLC. He was instrumental in growing the company to subsequently achieve its exit strategy, selling the company less than three years after its inception to American Tower Corporation. Dale then founded, and later sold, Nsight Technologies, LLC, a regional information technology consulting business. For the last decade, he has been a partner in Strategic Advisory Group, LLC, a commercial real estate development firm based in Ridgeland, MS.

Dale is a member of the Mississippi Bar Association and has served as a director on a variety of boards. Currently, he serves as Rear Commodore and a member of the board of the Jackson Yacht Club.

Scroll to Top

Partner With Us

Join us on the ground floor of a transformative journey with RAM Pharmaceuticals.

As we lead the charge in developing groundbreaking treatments for Severe Oral Mucositis and dental pain management, this is your chance to invest in a company poised for exponential growth. With FDA-approved innovations and a commitment to enhancing patient comfort, RAM Pharmaceuticals is setting new standards in the pharmaceutical industry.

Mark your calendars!

Starting December 15th, 2024, you can invest through StartEngine and be part of a profitable mission that makes a profound difference in the lives of countless cancer patients. Don’t miss your opportunity to be a catalyst for change!